Skip to main content Start main content

RA05_PRIZHANGAping560860rThe miniaturisation of biosensors has become crucial because of the great potential for in vivo biomarker detection and disease diagnostics as well as point-of-care testing during public health crises such as the coronavirus disease 2019 pandemic. Prof. Aping Zhang, Management Committee Member of the Photonics Research Institute (PRI), and his team members have invented an ultraminiature optical fiber-tip plasmonic biosensor for label-free biodetection.

RA051s20S0956566322008016gr1RA051s20S0956566322008016gr2

This biosensor is based on plasmonic gold nanoparticles (AuNPs) directly printed on the end face of a standard multimode optical fiber in the visible light range. An in-situ precision photoreduction technique has been developed to additively print the micropatterns of size-controlled AuNPs. The AuNPs exhibit distinct localised surface plasmon resonance, the peak wavelength of which provides an ideal spectral signal for label-free biodetection. The fabricated optical fiber-tip plasmonic biosensor can detect not only antibodies, but also the SARS-CoV-2 mimetic DNA sequence at a concentration level of 0.8 pM. This ultraminiature fiber-tip plasmonic biosensor provides a cost-effective biodetection technology for a myriad of applications ranging from point-of-care testing to in vivo diagnosis of stubborn diseases. 

The research results mentioned above has been published in the internationally renowned journal Biosensors and Bioelectronics (IF:12.54).

E_WEB_03

Further Reading

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here